Skip to main content
Clinical Trials/IRCT20171223038001N1
IRCT20171223038001N1
Recruiting
Phase 3

Comparison of the efficacy of Levofloxacin and Clarithromycin in quadruple therapy for the eradication of Helicobacter pylori

Esfahan University of Medical Sciences0 sites210 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Helicobacter pylori infection.
Sponsor
Esfahan University of Medical Sciences
Enrollment
210
Status
Recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Aged 18 years and older
  • Patients with dyspepsia and upper digestive tract symptoms
  • Peptic Ulcers in Upper Gastrointestinal Endoscopy
  • Helicobacter pylori infection in rapid test of urease
  • The desire to participate in the study
  • Lack of severe illness
  • Not having a history of upper gastrointestinal surgery
  • Not taking antibiotics, PPIs and NSAIDs in the last three months
  • Not having eradication history of Helicobacter pylori
  • Absence of ContraIndications for the Consumption of quadruple therapy

Exclusion Criteria

  • Low drug intake (for any reason)
  • Incidence of severe drug complications during the study

Outcomes

Primary Outcomes

Not specified

Similar Trials